MIRAGEN THERAPEUTICS, INC. Uncategorized Contracts & Agreements

24 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Indemnity Agreement between the Registrant and each of its directors and executive officers
MIRAGEN THERAPEUTICS, INC.
Biotechnology
DE
2024
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2024
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2023
Open Market Sale Agreement
MIRAGEN THERAPEUTICS, INC.
Biotechnology
DE
2021
Open Market Sale Agreement, dated April 23, 2021, by and between Viridian Therapeutics, Inc. and Jefferies LLC
MIRAGEN THERAPEUTICS, INC.
Biotechnology
NY
2021
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2021
Amendment to Research Subaward Agreement, entered into as of August 11, 2020, by and between Registrant and Yale University
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2020
Deferral Agreement between Silicon Valley Bank and the Registrant effective as of April 6, 2020
MIRAGEN THERAPEUTICS, INC.
Biotechnology
CA
2020
Amendment to Research Subaward Agreement, entered into as of April 7, 2020, by and between Registrant and Yale University
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2020
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2020
Amendment to Research Subaward Agreement, entered into as of October 11, 2019 and effective as of August 12, 2019, by and between Registrant and Yale University, as amended
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2019
Amendment to Research Subaward Agreement, entered into as of March 7, 2019 and effective as of September 1, 2018, by and between Registrant and Yale University, as amended
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2019
Research Subaward Agreement Amendment
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2017
SUBCONTRACT AGREEMENT BETWEEN YALE UNIVERSITY AND MIRAGEN THERAPEUTICS, INC.
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2016
NON-EMPLOYEE DIRECTOR CASH AND EQUITYCOMPENSATION POLICY
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2016
SECOND ADDENDUM
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2016
FIRST ADDENDUM
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2016
INDEMNITY AGREEMENT
MIRAGEN THERAPEUTICS, INC.
Biotechnology
DE
2016
SUPPORT AGREEMENT
MIRAGEN THERAPEUTICS, INC.
Biotechnology
DE
2016
SUPPORT AGREEMENT
MIRAGEN THERAPEUTICS, INC.
Biotechnology
DE
2016
UAMSBIOVENTURES LEASEAGREEMENT
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2016
SIGNAL GENETICS, INC.
MIRAGEN THERAPEUTICS, INC.
Biotechnology
NY
2015
SIGNAL GENETICS LLC 667 MADISON AVENUE 14TH FLOOR NEW YORK, NY 10065 October 9, 2013
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2014
AMENDED AND RESTATED SECURED DEMAND PROMISSORYNOTE
MIRAGEN THERAPEUTICS, INC.
Biotechnology
NY
2014